日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correction: Enhancement of the anti-tumor activity of FGFR1 inhibition in squamous cell lung cancer by targeting downstream signaling involved in glucose metabolism

更正：通过靶向葡萄糖代谢相关的下游信号通路，增强FGFR1抑制剂在鳞状细胞肺癌中的抗肿瘤活性

期刊:Oncotarget
影响因子:
doi:10.18632/oncotarget.28844
Fumarola, Claudia; Cretella, Daniele; Monica, Silvia La; Bonelli, Mara A; Alfieri, Roberta; Caffarra, Cristina; Quaini, Federico; Madeddu, Denise; Falco, Angela; Cavazzoni, Andrea; Digiacomo, Graziana; Mazzaschi, Giulia; Vivo, Valentina; Barocelli, Elisabetta; Tiseo, Marcello; Petronini, Pier Giorgio; Ardizzoni, Andrea
肺癌
肿瘤
肿瘤免疫
信号转导
代谢
细胞生物学
FGFR1
发表日期：2026
文献求助 收藏

Correction: The anti-tumor efficacy of CDK4/6 Inhibition is enhanced by the combination with PI3K/AKT/mTOR inhibitors through impairment of glucose metabolism in TNBC cells

更正：CDK4/6抑制剂与PI3K/AKT/mTOR抑制剂联合使用，可通过损害TNBC细胞的葡萄糖代谢来增强其抗肿瘤疗效。

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-025-03383-x
Cretella, Daniele; Ravelli, Andrea; Fumarola, Claudia; La Monica, Silvia; Digiacomo, Graziana; Cavazzoni, Andrea; Alfieri, Roberta; Biondi, Alessandra; Generali, Daniele; Bonelli, Mara; Petronini, Pier Giorgio
CDK4
肿瘤
mTOR
肿瘤免疫
代谢
细胞生物学
AKT
发表日期：2025
文献求助 收藏

Correction: Cavazzoni et al. Pemetrexed Enhances Membrane PD-L1 Expression and Potentiates T Cell-Mediated Cytotoxicity by Anti-PD-L1 Antibody Therapy in Non-Small-Cell Lung Cancer. Cancers 2020, 12, 666

更正：Cavazzoni 等人，《培美曲塞增强膜 PD-L1 表达并增强抗 PD-L1 抗体疗法在非小细胞肺癌中的 T 细胞介导的细胞毒性》，Cancers 2020, 12, 666

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17081254
Cavazzoni, Andrea; Digiacomo, Graziana; Alfieri, Roberta; La Monica, Silvia; Fumarola, Claudia; Galetti, Maricla; Bonelli, Mara; Cretella, Daniele; Barili, Valeria; Zecca, Alessandra; Giovannetti, Elisa; Fiorentino, Michelangelo; Tiseo, Marcello; Petronini, Pier Giorgio; Ardizzoni, Andrea
毒理研究
细胞生物学
PD-L1
肺癌
肿瘤
肿瘤免疫
T细胞
发表日期：2025
文献求助 收藏

Corrigendum: CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells

更正：CDK4/6抑制剂可提高乐伐替尼在肝癌细胞中的抗肿瘤疗效

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2024.1532291
Digiacomo, Graziana; Fumarola, Claudia; La Monica, Silvia; Bonelli, Mara; Cavazzoni, Andrea; Galetti, Maricla; Terenziani, Rita; Eltayeb, Kamal; Volta, Francesco; Zoppi, Silvia; Bertolini, Patrizia; Missale, Gabriele; Alfieri, Roberta; Petronini, Pier Giorgio
CDK4
肿瘤
肿瘤免疫
肝癌
细胞生物学
发表日期：2024
文献求助 收藏

Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators

EGFR突变型非小细胞肺癌细胞系对奥希替尼的固有耐药性是由细胞周期调节因子的改变引起的

期刊:Targeted Oncology
影响因子:4
doi:10.1007/s11523-023-01005-0
Volta, Francesco; La Monica, Silvia; Leonetti, Alessandro; Gnetti, Letizia; Bonelli, Mara; Cavazzoni, Andrea; Fumarola, Claudia; Galetti, Maricla; Eltayeb, Kamal; Minari, Roberta; Petronini, Pier Giorgio; Tiseo, Marcello; Alfieri, Roberta
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2023
文献求助 收藏

Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer

肺癌脂质代谢重编程：以EGFR突变型非小细胞肺癌为例的概述

期刊:Cells
影响因子:5.2
doi:10.3390/cells11030413
Eltayeb, Kamal; La Monica, Silvia; Tiseo, Marcello; Alfieri, Roberta; Fumarola, Claudia
肺癌
肿瘤
肿瘤免疫
EGF
代谢
代谢重编程
EGFR
细胞生物学
发表日期：2022
文献求助 收藏

CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma Cells

CDK4/6抑制剂可增强标准化疗对恶性胸膜间皮瘤细胞的疗效

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers14235925
Terenziani, Rita; Galetti, Maricla; La Monica, Silvia; Fumarola, Claudia; Zoppi, Silvia; Alfieri, Roberta; Digiacomo, Graziana; Cavazzoni, Andrea; Cavallo, Delia; Corradi, Massimo; Tiseo, Marcello; Petronini, Pier Giorgio; Bonelli, Mara
CDK4
细胞生物学
发表日期：2022
文献求助 收藏

CDK4/6 inhibitors improve the anti-tumor efficacy of lenvatinib in hepatocarcinoma cells.

CDK4/6 抑制剂可提高乐伐替尼对肝癌细胞的抗肿瘤疗效

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2022.942341
Digiacomo Graziana, Fumarola Claudia, La Monica Silvia, Bonelli Mara, Cavazzoni Andrea, Galetti Maricla, Terenziani Rita, Eltayeb Kamal, Volta Francesco, Zoppi Silvia, Bertolini Patrizia, Missale Gabriele, Alfieri Roberta, Petronini Pier Giorgio
细胞生物学
肿瘤
肝癌
肿瘤免疫
发表日期：2022
文献求助 收藏

Dual Inhibition of CDK4/6 and PI3K/AKT/mTOR Signaling Impairs Energy Metabolism in MPM Cancer Cells

CDK4/6 和 PI3K/AKT/mTOR 信号通路的双重抑制会损害 MPM 癌细胞的能量代谢

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms21145165
Bonelli, Mara; Terenziani, Rita; Zoppi, Silvia; Fumarola, Claudia; La Monica, Silvia; Cretella, Daniele; Alfieri, Roberta; Cavazzoni, Andrea; Digiacomo, Graziana; Galetti, Maricla; Petronini, Pier Giorgio
CDK4
肿瘤
mTOR
肿瘤免疫
信号转导
代谢
细胞生物学
AKT
发表日期：2020
文献求助 收藏

Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC

第三代 EGFR 抑制剂奥希替尼联合培美曲塞或顺铂在 EGFR 突变型非小细胞肺癌临床前模型中具有持久的抗肿瘤作用。

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-019-1240-x
La Monica, Silvia; Minari, Roberta; Cretella, Daniele; Flammini, Lisa; Fumarola, Claudia; Bonelli, Mara; Cavazzoni, Andrea; Digiacomo, Graziana; Galetti, Maricla; Madeddu, Denise; Falco, Angela; Lagrasta, Costanza Annamaria; Squadrilli, Anna; Barocelli, Elisabetta; Romanel, Alessandro; Quaini, Federico; Petronini, Pier Giorgio; Tiseo, Marcello; Alfieri, Roberta
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2019
文献求助 收藏